10.1096/fj.02-0847fje FASEB J
Explosive market growth for weight-loss medications The GLP-1 market is booming: $26 billion in sales in 2024, projected to hit $100470 billion annually by 2032, dominated by just two pharmaceutical giants: Novo Nordisk and Eli Lilly
Hai tc dng chnh ca Glutathione i vi da bao gm: Lm chm qu trnh lo ha da: Glutathione gip trung ha cc gc t do, gim thiu du hiu lo ha nh np nhn v lm cho da tr nn sn chc hn
Journal of Neuroinflammation 9, 276.CrossRefGoogle ScholarPubMed Koshal, P, Jamwal, S and Kumar, P (2018) Glucagon-like Peptide-1 (GLP-1) and neurotransmitters signaling in epilepsy: an insight review
Safety is especially important when considering higher doses, as these may increase the likelihood of side effects
(2000) Association between Helicobacter pylori cytotoxic type I CagA-positive strains and migraine with aura